High serum CA-125 level in active pulmonary tuberculosis

F. Sahin, H. Can, F. Atabey, S. Öztürk, A. Poluman (Istanbul, Turkey)

Source: Annual Congress 2005 - Clinical and diagnostic features in tuberculosis I
Session: Clinical and diagnostic features in tuberculosis I
Session type: Thematic Poster Session
Number: 2643

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Sahin, H. Can, F. Atabey, S. Öztürk, A. Poluman (Istanbul, Turkey). High serum CA-125 level in active pulmonary tuberculosis. Eur Respir J 2005; 26: Suppl. 49, 2643

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum IFN-γ and TNF-α levels in pulmonary tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 456s
Year: 2005

High serum periostin levels and the association with pulmonary tuberculosis
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018

Comparison of serum CA-125 levels in pulmonary tuberculosis, pleural tuberculosis and treated active pulmonary tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 453s
Year: 2005

The significance of serum CA-125 and various tumour markers in pulmonary and pleural tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 156s
Year: 2003

Usefulness of serum procalcitonin levels in pulmonary tuberculosis
Source: Eur Respir J 2011; 37: 371
Year: 2011



Hypercalcemia and low parathormone levels in active pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 155s
Year: 2003

Elevated serum adiponectin level in patients with mycobacterium avium-intracellulare complex pulmonary disease
Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis
Year: 2008

Neopterin levels differential diagnosis of active and inactive pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 341s
Year: 2006

Evaluation of sICAM-1 as a serum marker for follow-up of pulmonary tuberculosis therapy
Source: Eur Respir J 2005; 26: Suppl. 49, 454s
Year: 2005

Correlation of serum TNF-α, IL-4 and sIL-2R levels with radiologic and clinical manifestations in active pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 339s
Year: 2003

Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection
Source: Eur Respir J 2006; 28: Suppl. 50, 164s
Year: 2006

High serum levels of YKL-40 in IPF
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008


The relationship between level of C-reactive protein in blood serum and clinical manifestations of the disease in patients with pulmonary tuberculosis
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010

Comparison of the serum soluble IL-2 receptor levels in the differential diagnosis of pulmonary tuberculosis and lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 475s
Year: 2001

Profile of plasma cortisol levels in patients with pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 154s
Year: 2003

Level of C-reactive protein in blood serum of patients with MDR tuberculosis before and after treatment
Source: Eur Respir J 2007; 30: Suppl. 51, 201s
Year: 2007

Clinical significance of low serum isoniazid level among the patients with drug-sensitive pulmonary tuberculosis who showed delayed smear or culture conversion.
Source: International Congress 2018 – New developments in tuberculosis
Year: 2018



A comparative study on serum ADA levels in cavitary and non-cavitary pulmonary tuberculosis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 160s
Year: 2003

Elevated serum S100A4 levels in patients with silicosis
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019

High level of serum SP-D with normal range of KL-6 predicts a good prognosis of patients with fibrotic changes on HRCT
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010